Cargando…
Efficacy and safety of N-acetyl-l-leucine in Niemann–Pick disease type C
OBJECTIVE: To investigate the safety and efficacy of N-acetyl-l-leucine (NALL) on symptoms, functioning, and quality of life in pediatric (≥ 6 years) and adult Niemann–Pick disease type C (NPC) patients. METHODS: In this multi-national, open-label, rater-blinded Phase II study, patients were assesse...
Autores principales: | Bremova-Ertl, Tatiana, Claassen, Jens, Foltan, Tomas, Gascon-Bayarri, Jordi, Gissen, Paul, Hahn, Andreas, Hassan, Anhar, Hennig, Anita, Jones, Simon A., Kolnikova, Miriam, Martakis, Kyriakos, Raethjen, Jan, Ramaswami, Uma, Sharma, Reena, Schneider, Susanne A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8361244/ https://www.ncbi.nlm.nih.gov/pubmed/34387740 http://dx.doi.org/10.1007/s00415-021-10717-0 |
Ejemplares similares
-
N-acetyl-L-leucine for Niemann-Pick type C: a multinational double-blind randomized placebo-controlled crossover study
por: Fields, T, et al.
Publicado: (2023) -
A cross‐sectional, prospective ocular motor study in 72 patients with Niemann‐Pick disease type C
por: Bremova‐Ertl, Tatiana, et al.
Publicado: (2021) -
Retinal axonal degeneration in Niemann–Pick type C disease
por: Havla, Joachim, et al.
Publicado: (2020) -
A master protocol to investigate a novel therapy acetyl-l-leucine for three ultra-rare neurodegenerative diseases: Niemann-Pick type C, the GM2 gangliosidoses, and ataxia telangiectasia
por: Fields, T., et al.
Publicado: (2021) -
Genetic and laboratory diagnostic approach in Niemann Pick disease type C
por: McKay Bounford, K., et al.
Publicado: (2014)